Nh Theraguix

Developer of nanoparticle-based theranostic for the treatment of cancer

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2015 groups18 employees language nhtheraguix.com

Innovation

15 patent families (7 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 989 times.

YearFilings
20182
20194
20204
20217
20228
20237
20248
20254
20262

Investor mix

4 investors on record; lead investors include Bpifrance, Supernova Invest.

Investor typeCountShare
Venture capital125%
Private equity125%
Bank & private debt125%
Other / undisclosed125%
Coming soon